jan 1, 1989 - FDA approval for first atypical antidepressant: Bupropion (Wellbutrin)
Description:
Specifically designed to treat MDD with the aim of improving efficacy and safety (though it turned out to be just as efficacious) (Hillhouse & Porter, 2015). It uniquely inhibits the reuptake of dopamine and norepinephrine.
Added to timeline:
Date: